
Despite its impressive fundamentals,REGENERON PHARMACEUTICALS (NASDAQ:REGN) remains undervalued.
Discover REGENERON PHARMACEUTICALS (NASDAQ:REGN), an undervalued stock highlighted by our stock screener. REGN showcases solid financial health and profitability while maintaining an appealing valuation. We'll explore the details. Valuation Analysis …